Ankasa Regenerative Therapeutics Overview
- Year Founded
-
2014
- Status
-
Private
- Employees
-
5
- Latest Deal Type
-
Later Stage VC
- (Cancelled)
- Investors
-
5
Ankasa Regenerative Therapeutics General Information
Description
Developer of protein-based stem cell activation therapies designed to improve tissue repair and regeneration. The company's therapies enhance the osteogenic properties of patient-derived stem cells used in reconstructive surgeries and provide safe and effective enhancement of bone formation, enabling clinicians to reduce the rate of revision surgeries and their attendant complications.
Contact Information
Corporate Office
- 11099 North Torrey Pines Road
- Suite 290, La Jolla
- San Diego, CA 92037
- United States
Corporate Office
- 11099 North Torrey Pines Road
- Suite 290, La Jolla
- San Diego, CA 92037
- United States
Ankasa Regenerative Therapeutics Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 4. Later Stage VC | 01-Jan-2021 | Cancelled | Generating Revenue | |||
| 3. Later Stage VC | 13-Oct-2020 | Completed | Generating Revenue | |||
| 2. Grant | 01-Aug-2019 | $6.08M | $9.5M | Completed | Generating Revenue | |
| 1. Early Stage VC (Series A) | 30-Jul-2015 | $9.5M | $9.5M | Completed | Generating Revenue |
Ankasa Regenerative Therapeutics Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| Series A |
VC Exit Predictor
See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.
Opportunity Score
Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.
Exit Type
Evaluates the likelihood of a successful exit for investors, and the most likely exit type.
Ankasa Regenerative Therapeutics Related Research & Analysis
Explore institutional-grade private market research from our team of analysts.
-
Verticals
Ankasa Regenerative Therapeutics Patents
Ankasa Regenerative Therapeutics Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| AU-2018309026-A1 | Wnt compositions and methods of process from serum-free culturing conditions | Inactive | 01-Aug-2017 | ||
| US-20200399588-A1 | Wnt compositions and methods of process from serum-free culturing conditions | Pending | 01-Aug-2017 | ||
| GB-2610090-B | Wnt compositions and methods of process from serum-free culturing conditions | Active | 01-Aug-2017 | ||
| CA-3071638-A1 | Wnt compositions and methods of process from serum-free culturing conditions | Pending | 01-Aug-2017 | ||
| EP-3661475-A1 | Wnt compositions and methods of process from serum-free culturing conditions | Pending | 01-Aug-2017 | C12N5/0031 |
Ankasa Regenerative Therapeutics Signals
Growth Rate
Growth
Size Multiple
Key Data Points
Similarweb Unique Visitors
Majestic Referring Domains
Ankasa Regenerative Therapeutics Investors (5)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| California Institute for Regenerative Medicine | Government | |||
| Avalon Bioventures | Venture Capital | Minority | ||
| Correlation Ventures | Venture Capital | Minority | ||
| Heraeus Group | Corporation | Minority | ||
| Stanford University Venture Fund | Venture Capital | Minority |
Ankasa Regenerative Therapeutics FAQs
-
When was Ankasa Regenerative Therapeutics founded?
Ankasa Regenerative Therapeutics was founded in 2014.
-
Where is Ankasa Regenerative Therapeutics headquartered?
Ankasa Regenerative Therapeutics is headquartered in San Diego, CA.
-
What is the size of Ankasa Regenerative Therapeutics?
Ankasa Regenerative Therapeutics has 5 total employees.
-
What industry is Ankasa Regenerative Therapeutics in?
Ankasa Regenerative Therapeutics’s primary industry is Drug Discovery.
-
Is Ankasa Regenerative Therapeutics a private or public company?
Ankasa Regenerative Therapeutics is a Private company.
-
What is Ankasa Regenerative Therapeutics’s current revenue?
The current revenue for Ankasa Regenerative Therapeutics is .
-
How much funding has Ankasa Regenerative Therapeutics raised over time?
Ankasa Regenerative Therapeutics has raised $15.5M.
-
Who are Ankasa Regenerative Therapeutics’s investors?
California Institute for Regenerative Medicine, Avalon Bioventures, Correlation Ventures, Heraeus Group, and Stanford University Venture Fund have invested in Ankasa Regenerative Therapeutics.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read blog » -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process »
